Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Breaking news Health & Science Companies
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Social issues Breaking News: Politics Biotechnology
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Abbvie Inc Politics Eli Lilly and Co
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Healthy Returns Health & Science Health care industry
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Pharmaceuticals US: News Companies
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Science
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Healthy Returns Altimmune Inc Health & Science
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Science
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Roche Holding AG
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Business
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Biotechnology Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Bristol/Myers Squibb Co Healthy Returns Health & Science
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Biotech and Pharmaceuticals Health & Science Novo Nordisk A/S
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Pharmaceuticals Business News Roche Holding AG
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Healthy Returns Merck & Co Inc Health & Science
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Pfizer Inc Eli Lilly and Co Business
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Investment strategy U/S/ Markets Investing
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags UnitedHealth Group Inc Health & Science Companies
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Tesla Inc Paramount Global Cryptocurrency
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Daily Open JPMorgan Chase & Co Stock indices and averages
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Stock markets Biotechnology Health care costs
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Deutsche Bank AG Pharmaceuticals US: News
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Oracle Corp Eli Lilly and Co Technology
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Gilead Sciences Inc Health & Science Healthy Returns
From CNBC.com News
5 things to know before the stock market opens
Tags Walt Disney Co Nasdaq Inc Business News
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Novo Nordisk A/S China Economy Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Biotechnology Health care industry Business News
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Europe Markets Markets Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.